Indications
| Mesh Heading | Maximum Phase | Reference |
|---|---|---|
| Autoimmune Diseases | Phase 1 | ClinicalTrials |
| Multiple Myeloma; Neoplasms, Plasma Cell | Phase 1/Phase 2 | ClinicalTrials |
| Multiple Myeloma; Neoplasms, Plasma Cell | Phase 1 | ClinicalTrials |
| Lupus Erythematosus, Systemic | Phase 1 | ClinicalTrials |
CONTENTS